Investigation on metabolism of cisplatin resistant ovarian cancer using a genome scale metabolic model and microarray data
Authors:
Open Access
- 1 March 2015
- journal article
- research article
- Vol. 18 (3) , 267-276
Abstract
Objective(s): Many cancer cells show significant resistance to drugs that kill drug sensitive cancer cells and non-tumor cells and such resistance might be a consequence of the difference in metabolism. Therefore, studying the metabolism of drug resistant cancer cells and comparison with drug sensitive and normal cell lines is the objective of this research. Material and Methods: Metabolism of cisplatin resistant and sensitive A2780 epithelial ovarian cancer cells and normal ovarian epithelium has been studied using a generic human genome-scale metabolic model and transcription data. Result: The results demonstrate that the most different metabolisms belong to resistant and normal models, and the different reactions are involved in various metabolic pathways. However, large portion of distinct reactions are related to extracellular transport for three cell lines. Capability of metabolic models to secrete lactate was investigated to find the origin of Warburg effect. Computational results introduced SLC25A10 gene, which encodes mitochondrial dicarboxylate transporter involved in exchanging of small metabolites across the mitochondrial membrane that may play key role in high growing capacity of sensitive and resistant cancer cells. The metabolic models were also used to find single and combinatorial targets that reduce the cancer cells growth. Effect of proposed target genes on growth and oxidative phosphorylation of normal cells were determined to estimate drug side-effects. Conclusion: The deletion results showed that although the cisplatin did not cause resistant cancer cells death, but it shifts the cancer cells to a more vulnerable metabolism.Keywords
This publication has 38 references indexed in Scilit:
- Using the reconstructed genome‐scale human metabolic network to study physiology and pathologyJournal of Internal Medicine, 2011
- Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0Nature Protocols, 2011
- Predicting selective drug targets in cancer through metabolic networksMolecular Systems Biology, 2011
- A protocol for generating a high-quality genome-scale metabolic reconstructionNature Protocols, 2010
- Linking high-resolution metabolic flux phenotypes and transcriptional regulation in yeast modulated by the global regulator Gcn4pProceedings of the National Academy of Sciences, 2009
- The utility of MAS5 expression summary and detection call algorithmsBMC Bioinformatics, 2007
- Global reconstruction of the human metabolic network based on genomic and bibliomic dataProceedings of the National Academy of Sciences, 2007
- Ovarian cancer: strategies for overcoming resistance to chemotherapyNature Reviews Cancer, 2003
- Superoxide activates mitochondrial uncoupling proteinsNature, 2002
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996